Bafna Pharmaceuticals Limited (NSE: BAFNAPH), ISIN INE878I01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BAFNAPH last traded at ₹263.95 (+1.99%), with a 52-week range of ₹77.01 to ₹263.95 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 75.00%, FIIs 9.34%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 60/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.